Treatment with radioactive iodine (radioiodine) was able to cure 92% of patients with thyrotoxicosis in a single-center New Zealand study of 222 patients treated in 2015. The study provides ...

Graphical Abstract. Relative survival with and without radioiodine therapy (RAI) in intermediate risk papillary thyroid cancer (PTC) and low risk, minimally invasive follicular thyroid cancer (FTC). A ...

A recent phase 3 trial found that 5-year recurrence-free survival was similar among patients who did and did not receive postoperative radioiodine, indicating the treatment can be safely avoided in ...

Please provide your email address to receive an email when new articles are posted on . Among adults with Graves’ disease, thyroid dysfunction was common and often recurrent during the first 12 months ...

Please provide your email address to receive an email when new articles are posted on . Researchers conducted a prospective, randomized, phase 3 trial including 730 patients with low-risk ...

In patients with low-risk thyroid cancer undergoing thyroidectomy, a strategy omitting radioiodine was noninferior to an ablation strategy using radioiodine when it came to the occurrence of certain ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today announced results from a phase 2 investigator-sponsored trial (IST) of cabozantinib for the first-line treatment of ...

Dedicated at Massachusetts General Hospital, Boston, on Oct. 8, 2021. On a spring day in Boston in 1941, a young doctor from Massachusetts General Hospital (MGH) met a woman for a drink. But this was ...

Health care specialists share insight on the work-up of patients with iodine-refractory differentiated thyroid cancer and how this may affect systemic therapy options. Lori Wirth, MD: Let’s chat a ...

Expert perspectives on the process of surgery and radiation therapy used for less severe cases of differentiated thyroid cancer. Bryan McIver, MD: The key message I want to convey is that we have to ...

Comparative Toxicities and Cost of Intensity-Modulated Radiotherapy, Proton Radiation, and Stereotactic Body Radiotherapy Among Younger Men With Prostate Cancer Patients with WDTC were identified from ...